Subsidy Information and Financing Scheme MAFVedolizumab (Entyvio) Infusion 300 mg Additional clinical criteria applies Treatment of adults with moderately to severely active Crohn’... See all × MAFVedolizumab (Entyvio) Infusion 300 mg Additional clinical criteria applies Treatment of adults with moderately to severely active Crohn’s disease who have failed both conventional therapy and anti-TNFα biologics.
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Entyvio Infusion 300 mg Changi General Hospital Khoo Teck Puat Hospital National University Hospital Singapore General Hospital Tan Tock Seng Hospital
INTRAVENOUS Select a brand starting with the letter: E ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL [SIN14950P]
SUBCUTANEOUS Select a brand starting with the letter: E ENTYVIO SOLUTION FOR INJECTION IN PRE-FILLED PEN 108MG/0.68ML [SIN16673P]